UBS upgraded UnitedHealth (UNH) to buy from neutral. The analyst notes that UNH’s “strong” 3Q is a “clearing event that should pave the way for improved valuation.” UBS raised UNH’s price target to $640 from $520. Jenny Horne discusses this along with Pfizer (PFE) which cut its full-year guidance as demand for Covid-19 vaccines fall. PFE’s shares are near a 52-week low. Tune in to find out more about the stock market today.
Morning Trade Live
16 Oct 2023
SHARE
Market On Close
08 Feb 2024
Morning Trade Live
14 Mar 2024
Trading 360
30 Jan 2024
Morning Trade Live
29 Jan 2024
Morning Trade Live
16 Feb 2024
Market On Close
30 Jan 2024